Target intelligence / Profile preview

Small nuclear ribonucleoprotein polypeptide A (SNRPA)

Target
SNRPA
Molecular classification
RNA-binding protein, Small nuclear ribonucleoprotein (snRNP) complex component, Spliceosomal protein
01

Overview

Small nuclear ribonucleoprotein polypeptide A (SNRPA) is a core protein component of the U1 small nuclear ribonucleoprotein (snRNP) complex, which is essential for the recognition of the 5' splice site in precursor mRNAs during pre-mRNA splicing. SNRPA binds specifically to stem loop II of U1 snRNA, facilitating spliceosome assembly and regulation of RNA processing. The protein also autoregulates its own pre-mRNA by inhibiting polyadenylation via dimerization, thereby linking splicing and polyadenylation. In immune cells, SNRPA has been shown to modulate expression and alternative polyadenylation of specific mRNAs such as STAT5B, influencing Th1 differentiation. Germline mutations in SNRPA result in neurodevelopmental syndromes, and dysregulation of SNRPA has been implicated in various cancers by affecting cell survival and proliferation through RNA processing, including binding to G-quadruplex structures in oncogenic mRNAs. SNRPA interacts with factors such as CDC5L and has a role in nuclear retention of long noncoding RNAs. Despite its critical roles, SNRPA is not currently considered a direct therapeutic target and there are no drugs clinically targeting it.

Other names
U1 small nuclear ribonucleoprotein AU1-AU1AMud1U1 snRNP AU1 snRNP-specific protein AU1 snRNP-specific ASNRPA
02

Biological functions

Pre-mRNA splicingRNA bindingPolyadenylation inhibitionRegulation of RNA processingRegulation of alternative polyadenylation in activated T cellsNuclear retention of spliced long noncoding RNAs
03

Disease associations

Neurodevelopmental defects (associated with germline mutations)Mixed connective tissue diseaseConnective tissue diseaseCancer (gastric cancer, colorectal cancer: implicated in cell proliferation, metastasis, and oncogenic RNA processing)

Beyond the preview

Go deeper on Small nuclear ribonucleoprotein polypeptide A (SNRPA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small nuclear ribonucleoprotein polypeptide A (SNRPA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call